Radiotherapy, Temozolomide, and Bevacizumab Followed by Irinotecan, Temozolomide and Bevacizumab in Newly Diagnosed Glioblastoma Multiforme: Preliminary Results from an Ongoing Phase II Trial


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kirkpatrick, JP; Desjardins, A; Reardon, DA; Vredenburgh, JJ

Published Date

  • September 2008

Published In

Volume / Issue

  • 72 / 1

Start / End Page

  • S209 - S209

Published By

International Standard Serial Number (ISSN)

  • 0360-3016

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2008.06.1537